Stockscreener 앱 받기
5.19
2.08%
-0.11
전일 마감가:
$5.30
열려 있는:
$5.475
하루 거래량:
29,717
Relative Volume:
0.12
시가총액:
$2.77M
수익:
$1.75M
순이익/손실:
$-5.68M
주가수익비율:
-1.0651
EPS:
-4.8726
순현금흐름:
-
1주 성능:
-8.47%
1개월 성능:
-20.76%
6개월 성능:
+946.16%
1년 성능:
+1,541%
1일 변동 폭
$5.06
$5.48
1주일 범위
$5.06
$6.085
52주 변동 폭
$0.197
$8.50
Scisparc Ltd Stock (SPRC) Company Profile
SPRC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
5.19 | 2.97M | 1.75M | -5.68M | 0 | -4.8726 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Scisparc Ltd 주식(SPRC)의 최신 뉴스
SciSparc and Clearmind Publish Patent for Novel Obesity Therapy - TipRanks
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - The Manila Times
SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire
Breakthrough Obesity Treatment Patent Targets One-Third of US Adults with Metabolic Syndrome - Stock Titan
AI Trend Models Suggest Bounce for SciSparc Ltd.Community Entry Consensus Trade Ideas Shared - beatles.ru
What catalysts could drive SciSparc Ltd. stock higher in 2025Master the art of timing market moves - Jammu Links News
What is the risk reward ratio of investing in SciSparc Ltd. stockCapitalize on fast-moving stock opportunities - Jammu Links News
How many analysts rate SciSparc Ltd. as a “Buy”Market-leading growth rates - Jammu Links News
How strong is SciSparc Ltd. company’s balance sheetDynamic growth stocks - Jammu Links News
When is SciSparc Ltd. stock expected to show significant growthUnlock powerful insights from market experts - Jammu Links News
What are the technical indicators suggesting about SciSparc Ltd.Tremendous portfolio expansion - Jammu Links News
Why is SciSparc Ltd. stock attracting strong analyst attentionPhenomenal returns - Jammu Links News
How does SciSparc Ltd. compare to its industry peersAchieve consistent profits with expert advice - Jammu Links News
Is it the right time to buy SciSparc Ltd. stockOutperformance with explosive growth - Jammu Links News
What is the dividend policy of SciSparc Ltd. stockBuild wealth steadily with proven stock picks - Jammu Links News
What are the latest earnings results for SciSparc Ltd.High-octane financial growth - Jammu Links News
What drives SciSparc Ltd. stock priceUnlock high-yield investment opportunities - jammulinksnews.com
How volatile is SciSparc Ltd. stock compared to the marketLow Risk Report For Consistent Profits - Jammu Links News
SciSparc Announces Patent Filing and Merger Updates - TipRanks
SciSparc's Proposed Merger with AutoMax Motors Advances with SEC Approval and Shareholder Meetings Scheduled - AInvest
SciSparc regains compliance with Nasdaq’s listing rule - MSN
SciSparc Announces Updates Regarding Proposed Merger; Form - GlobeNewswire
SciSparc sets shareholder vote dates for AutoMax merger By Investing.com - Investing.com Nigeria
SciSparc sets shareholder vote dates for AutoMax merger - Investing.com Australia
SciSparc Secures Critical SEC Approval for Electric Vehicle Merger with AutoMax Motors - Stock Titan
SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC - Taiwan News
SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire
Breakthrough Patent: New Drug Combination Targets 890M Obesity Patients and Fatty Liver Disease - Stock Titan
Best data tools to analyze SciSparc Ltd. stockFree Buy Low Sell High Stock Watch - Newser
Moving Average Trends for SciSparc Ltd. Stock: What They IndicateSmart Forecast Signals from AI Models - Newser
Evaluating SciSparc Ltd. with trendline analysisFree Day Trading Signals With High Precision - Newser
Quantitative breakdown of SciSparc Ltd. recent moveFree Trade Setups With Clear Risk Limits - Newser
What moving averages say about SciSparc Ltd.Free Expert Verified Stock Trade Ideas - Newser
Does SciSparc Ltd. stock pay reliable dividendsWeekly Stock Picks with Trend Confidence - Newser
SciSparc Ltd.’s Price Action Aligns with Quant SignalsRisk Controlled Picks With Real Returns Outlined - beatles.ru
Will SciSparc Ltd. Stock Benefit from AI and Green Energy TrendsEarnings Based Stock Performance Forecast - Newser
How SciSparc Ltd. stock performs during market volatilityTrade Setup Builder with Custom Alerts - Newser
Is SciSparc Ltd. in Accumulation Phase NowWeekly Hot Picks With Buy Confidence Released - beatles.ru
SciSparc Ltd. Could See a Relief Rally From SupportEntry Alert Based on Volume Spikes Detected - metal.it
Is SciSparc Ltd. a growth stock or a value stockPhenomenal capital gains - Jammu Links News
Scisparc Ltd (SPRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):